Abstract
We revisited the Congo red analogue 2,5-bis(4′-hydroxy-3′-carboxy-styryl)benzene (X-34) to develop this highly fluorescent amyloid dye for imaging Alzheimer's disease (AD) pathology comprising Aβ and Tau fibrils. A selection of ligands with distinct optical properties were synthesized by replacing the central benzene unit of X-34, with other heterocyclic moieties. Full photophysical characterization was performed, including recording absorbance and fluorescence spectra, Stokes shift, quantum yield and fluorescence lifetimes. All ligands displayed high affinity towards recombinant amyloid fibrils of Aβ1-42 (13–300 nm Kd) and Tau (16–200 nm Kd) as well as selectivity towards the corresponding disease-associated protein aggregates in AD tissue. We observed that these ligands efficiently displaced X-34, but not Pittsburgh compound B (PiB) from recombinant Aβ1-42 amyloid fibrils, arguing for retained targeting of the Congo red type binding site. We foresee that the X-34 scaffold offers the possibility to develop novel high-affinity ligands for Aβ pathology found in human AD brain in a different mode compared with PiB, potentially recognizing different polymorphs of Aβ fibrils.
| Original language | English |
|---|---|
| Pages (from-to) | 7210-7216 |
| Number of pages | 7 |
| Journal | Chemistry - A European Journal |
| Volume | 24 |
| Issue number | 28 |
| DOIs | |
| State | Published - May 17 2018 |
Bibliographical note
Publisher Copyright:© 2018 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Funding
Our work was funded by the China Scholarship Council, the Swedish Research Council (2015-04521), the Gçran Gustafsson Foundation, the Swedish Alzheimer Foundation, the Swedish Brain foundation, Linkçping University (LiU-Neuro), NIH/NINDS (R21 NS080576). We thank Hamid Shirani for discussions and advice on chemical synthesis. We are also grateful to Samuel Svensson from CBD solutions for material from Tissue solutions and discussions on tau pathology and tau ligands. We also thank David Colby for the 0N4R tau plasmid and Sara Linse for the Ab1-42 plasmid. Our work was funded by the China Scholarship Council, the Swedish Research Council (2015-04521), the Göran Gustafsson Foundation, the Swedish Alzheimer Foundation, the Swedish Brain foundation, Linköping University (LiU-Neuro), NIH/NINDS (R21 NS080576). We thank Hamid Shirani for discussions and advice on chemical synthesis. We are also grateful to Samuel Svensson from CBD solutions for material from Tissue solutions and discussions on tau pathology and tau ligands. We also thank David Colby for the 0N4R tau plasmid and Sara Linse for the Aβ1-42 plasmid.
| Funders | Funder number |
|---|---|
| Gçran Gustafsson Foundation | |
| Linkçping University | |
| NIH/NINDS | |
| Swedish Alzheimer Foundation | |
| Swedish Brain foundation | |
| National Institute of Neurological Disorders and Stroke | R21 NS080576 |
| Göran Gustafssons Stiftelse för Naturvetenskaplig och Medicinsk Forskning | |
| Vetenskapsrådet | 2015-04521 |
| China Scholarship Council |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Alzheimer's disease
- amyloid ligands
- dyes/pigments
- fluorescence
- microscopy
ASJC Scopus subject areas
- General Chemistry
- Catalysis
- Organic Chemistry
Fingerprint
Dive into the research topics of 'Detection and Imaging of Aβ1-42 and Tau Fibrils by Redesigned Fluorescent X-34 Analogues'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver